Garrett Motion Inc. (GTX) · Oct 29, 2026 · Earnings
Beat — Diluted EPS $0.51 vs ~$0.47 consensus; sales $930M vs ~$941M
Garrett Motion’s Q3 earnings beat profit expectations as margins and cash flow improved, but revenue missed consensus and guidance was reaffirmed.
Garrett is still a turbocharger-led supplier using its engineering base to expand into electric propulsion, fuel-cell compressors, thermal management and industrial cooling as vehicle electrification gradually reshapes its core market. Its zero-emission and industrial products are moving from development toward production, but the business remains primarily an automotive and commercial-vehicle supplier.
Profit beat the market’s bar despite a revenue miss. Diluted EPS was $0.51 versus a published consensus of roughly $0.47, while revenue was $930 million versus approximately $941 million expected. That makes this a profit-led beat rather than a clean top-line win. The company said, “Net sales for the third quarter of 2026 were $930million,” and “Net income for the third quarter of 2026 was $97million.”
The quality of the beat was operating leverage, not volume. Adjusted EBIT rose 14% to $152 million and margin expanded to 16.3% from 14.7%, helped by product mix, pricing and productivity. That offset lower sales volume, unfavorable foreign exchange and higher research and development costs. The result suggests Garrett is protecting profitability while gasoline demand softens in China and growth shifts toward diesel, commercial vehicles, industrial applications and aftermarket demand.
Cash generation strengthened materially. Operating cash flow increased to $135 million from $100 million, while adjusted free cash flow rose to $136 million from $107 million. That gives the company room to continue reducing debt and returning capital, although working capital still absorbed cash year to date.
| Figure | Q3 2026 | Q3 2025 | Consensus / prior outlook |
|---|---|---|---|
| Net sales (Financial Highlights) | $930M | $902M | ~$941M |
| Diluted EPS (Income Statement) | $0.51 | $0.38 | ~$0.47 |
| Adjusted EBIT (Adjusted EBIT reconciliation) | $152M | $133M | |
| Adjusted EBIT margin (Adjusted EBIT reconciliation) | 16.3% | 14.7% | |
| Operating cash flow (Cash Flow statement) | $135M | $100M | |
| Adjusted free cash flow (Free Cash Flow reconciliation) | $136M | $107M | |
| 2026 adjusted EBIT outlook (Full Year Outlook) | $570M–$590M | $560M–$600M prior | |
| 2026 adjusted free cash flow outlook (Full Year Outlook) | $410M–$450M | $385M–$475M prior |
Guidance was reaffirmed, not raised. Every full-year midpoint stayed the same: $3.80 billion of sales, $344.5 million of net income, $580 million of adjusted EBIT and $430 million of adjusted free cash flow. The ranges narrowed, improving confidence around the outcome but adding no new earnings power. Management explicitly said it “reaffirm[ed] our 2026 mid-point outlook.”
Capital returns and debt reduction add a useful secondary signal. Garrett authorized a new $250 million share-repurchase program for 2027, declared another $0.08 dividend and made a $50 million voluntary early repayment on its term loan. Those actions reinforce the stronger cash-flow profile, but they are capital-allocation decisions rather than evidence that the underlying demand picture has materially changed.
Bottom line: Garrett delivered a narrow earnings beat because mix, pricing and productivity more than offset softer volume, but the revenue miss and unchanged guidance keep this from being a full-blown acceleration story. The filing modestly strengthens the operating and cash-flow case while leaving the broader growth outlook largely intact.
Q4 earnings and 2027 outlook, early February
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!